GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 4, 2013, Pages 934-944

  Blyszczuk, Przemyslaw ^a,b   Behnke, Silvia ^c   Lüscher, Thomas F ^a,d   Eriksson, Urs ^a,b   Kania, Gabriela ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Institute of Radiology   (Switzerland)

^c Sophistolab AG   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

GM CSF; Inflammatory dendritic cells; Inflammatory progenitors; Myocarditis

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; HEART FAILURE; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; MYOCARDITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CELL MOVEMENT; CELL PROLIFERATION; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNIZATION; INFLAMMATION; MICE; MICE, INBRED BALB C; MONOCYTES; MYOCARDITIS; MYOCARDIUM; MYOSINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

MUS;

EID: 84875080078     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.10.008     Document Type: Article

References (47)

1. Rose N.R. Infection, mimics, and autoimmune disease. J. Clin. Investig. 2001, 107(8):943-944.
2. Neu N., Rose N.R., Beisel K.W., Herskowitz A., Gurri-Glass G., Craig S.W. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 1987, 139(11):3630-3636.
3. Baldeviano G.C., Barin J.G., Talor M.V., Srinivasan S., Bedja D., Zheng D., Gabrielson K., Iwakura Y., Rose N.R., Cihakova D. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ. Res. 2010, 106(10):1646-1655.
4. Blyszczuk P., Kania G., Dieterle T., Marty R.R., Valaperti A., Berthonneche C., Pedrazzini T., Berger C.T., Dirnhofer S., Matter C.M., Penninger J.M., Luscher T.F., Eriksson U. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ. Res. 2009, 105(9):912-920.
5. Kania G., Blyszczuk P., Stein S., Valaperti A., Germano D., Dirnhofer S., Hunziker L., Matter C.M., Eriksson U. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ. Res. 2009, 105(5):462-470.
6. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8(7):533-544.
7. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176(6):1693-1702.
8. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179(4):1109-1118.
9. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 1996, 184(2):695-706.
10. Vremec D., Lieschke G.J., Dunn A.R., Robb L., Metcalf D., Shortman K. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 1997, 27(1):40-44.
11. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7(1):19-30.
12. van de Laar L., Coffer P.J., Woltman A.M. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood 2012, 119(15):3383-3393.
13. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., Shortman K. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 2006, 7(6):663-671.
14. Greter M., Helft J., Chow A., Hashimoto D., Mortha A., Agudo-Cantero J., Bogunovic M., Gautier E.L., Miller J., Leboeuf M., Lu G., Aloman C., Brown B.D., Pollard J.W., Xiong H., Randolph G.J., Chipuk J.E., Frenette P.S., Merad M. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 2012, 36(6):1031-1046.
15. Gasson J.C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991, 77(6):1131-1145.
16. Hamilton J.A., Anderson G.P. GM-CSF biology. Growth Factors 2004, 22(4):225-231.
17. Matsumori A., Yamada T., Suzuki H., Matoba Y., Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br. Heart J. 1994, 72(6):561-566.
18. Parissis J.T., Korovesis S., Giazitzoglou E., Kalivas P., Katritsis D. Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. Int. J. Cardiol. 2002, 83(1):13-21.
19. Parissis J., Filippatos G., Adamopoulos S., Li X., Kremastinos D.T., Uhal B.D. Hematopoietic colony stimulating factors in cardiovascular and pulmonary remodeling: promoters or inhibitors?. Curr. Pharm. Des. 2006, 12(21):2689-2699.
20. Parissis J.T., Adamopoulos S., Venetsanou K., Kostakis G., Rigas A., Karas S.M., Kremastinos D. Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction. Eur. Cytokine Netw. 2004, 15(2):139-144.
21. Parissis J.T., Adamopoulos S., Venetsanou K.F., Mentzikof D.G., Karas S.M., Kremastinos D.T. Clinical and neurohormonal correlates of circulating granulocyte-macrophage colony-stimulating factor in severe heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 2000, 86((6):707-710. (A709-710).
22. Leon B., Lopez-Bravo M., Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007, 26(4):519-531.
23. Le Borgne M., Etchart N., Goubier A., Lira S.A., Sirard J.C., van Rooijen N., Caux C., Ait-Yahia S., Vicari A., Kaiserlian D., Dubois B. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006, 24(2):191-201.
24. Eriksson U., Ricci R., Hunziker L., Kurrer M.O., Oudit G.Y., Watts T.H., Sonderegger I., Bachmaier K., Kopf M., Penninger J.M. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 2003, 9(12):1484-1490.
25. Sonderegger I., Iezzi G., Maier R., Schmitz N., Kurrer M., Kopf M. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 2008, 205(10):2281-2294.
26. Campbell I.K., Rich M.J., Bischof R.J., Dunn A.R., Grail D., Hamilton J.A. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 1998, 161(7):3639-3644.
27. McQualter J.L., Darwiche R., Ewing C., Onuki M., Kay T.W., Hamilton J.A., Reid H.H., Bernard C.C. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 2001, 194(7):873-882.
28. Cook A.D., Braine E.L., Campbell I.K., Rich M.J., Hamilton J.A. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 2001, 3(5):293-298.
29. Eriksson U., Kurrer M.O., Schmitz N., Marsch S.C., Fontana A., Eugster H.P., Kopf M. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 2003, 107(2):320-325.
30. Valaperti A., Marty R.R., Kania G., Germano D., Mauermann N., Dirnhofer S., Leimenstoll B., Blyszczuk P., Dong C., Mueller C., Hunziker L., Eriksson U. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J. Immunol. 2008, 180(4):2686-2695.
31. Kania G., Blyszczuk P., Valaperti A., Dieterle T., Leimenstoll B., Dirnhofer S., Zulewski H., Eriksson U. Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis. Cardiovasc. Res. 2008, 80(2):236-245.
32. Marty R.R., Dirnhofer S., Mauermann N., Schweikert S., Akira S., Hunziker L., Penninger J.M., Eriksson U. MyD88 signaling controls autoimmune myocarditis induction. Circulation 2006, 113(2):258-265.
33. Campbell I.K., van Nieuwenhuijze A., Segura E., O'Donnell K., Coghill E., Hommel M., Gerondakis S., Villadangos J.A., Wicks I.P. Differentiation of inflammatory dendritic cells is mediated by NF-kappaB1-dependent GM-CSF production in CD4 T cells. J. Immunol. 2011, 186(9):5468-5477.
34. Codarri L., Gyulveszi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., Becher B. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12(6):560-567.
35. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., Zhang G.X., Dittel B.N., Rostami A. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011, 12(6):568-575.
36. Smith S.C., Allen P.M. The recognition of self-antigens and autoimmune disease. Curr. Opin. Immunol. 1991, 3(1):22-25.
37. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19(1):59-70.
38. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000, 1(4):311-316.
39. Belladonna M.L., Volpi C., Bianchi R., Vacca C., Orabona C., Pallotta M.T., Boon L., Gizzi S., Fioretti M.C., Grohmann U., Puccetti P. Cutting edge: autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol. 2008, 181(8):5194-5198.
40. Seifert T., Enzinger C., Ropele S., Storch M.K., Strasser-Fuchs S., Fazekas F. Relapsing acute transverse myelitis: a specific entity. Eur. J. Neurol. 2005, 12(9):681-684.
41. Skundric D.S. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective. Curr. Neurovasc. Res. 2005, 2(4):349-362.
42. Maekawa Y., Anzai T., Yoshikawa T., Sugano Y., Mahara K., Kohno T., Takahashi T., Ogawa S. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J. Am. Coll. Cardiol. 2004, 44(7):1510-1520.
43. Naito K., Anzai T., Sugano Y., Maekawa Y., Kohno T., Yoshikawa T., Matsuno K., Ogawa S. Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction. J. Immunol. 2008, 181(8):5691-5701.
44. Bussolino F., Wang J.M., Defilippi P., Turrini F., Sanavio F., Edgell C.J., Aglietta M., Arese P., Mantovani A. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989, 337(6206):471-473.
45. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5(4):434-438.
46. Tashiro H., Shimokawa H., Yamamoto K., Nagano M., Momohara M., Muramatu K., Takeshita A. Monocyte-related cytokines in acute myocardial infarction. Am. Heart J. 1995, 130(3 Pt 1):446-452.
47. Antman K.S., Griffin J.D., Elias A., Socinski M.A., Ryan L., Cannistra S.A., Oette D., Whitley M., Frei E. Schnipper LE: effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N. Engl. J. Med. 1988, 319(10):593-598.